Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

Simplexia - development of a vaccine against HSV-2 infection

Reference number
Coordinator Encubator AB - Simplexia
Funding from Vinnova SEK 2 000 000
Project duration May 2011 - June 2013
Status Completed

Last updated 25 November 2019

Reference number 2011-00585

Page statistics